Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.12.19
Z6尊龙:关于联营公司君圣泰医药拟在香港联交所主板上市的通告
2023.12.18
Z6尊龙:关于召开2024年第一次暂时股东大会的通知通告
2023.12.18
Z6尊龙:关于修订《公司章程》等相关制度的通告
2023.12.18
Z6尊龙:第六届董事会第六次聚会决议通告
2023.12.18
Z6尊龙:2023年第一次暂时股东大会、2023年第一次A股种别股东聚会及第一次H股种别股东会...
2023.12.08
Z6尊龙:关于延伸员工持股妄想存续期的通告
2023.12.08
Z6尊龙:第六届董事会第六次聚会决议通告
2023.11.21
Z6尊龙:第六届董事会第五次聚会决议通告
2023.11.21
Z6尊龙:第六届监事会第四次聚会决议通告
2023.11.21
Z6尊龙:关于变换H股召募资金使用用途的通告
第一页
上一页
2
3
4
5
6
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】